Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Atea Pharmaceuticals, Inc. Director's Dealing 2020

Oct 30, 2020

33577_dirs_2020-10-29_ba352224-a919-486e-8120-9c97ac7326ee.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Atea Pharmaceuticals, Inc. (AVIR)
CIK: 0001593899
Period of Report: 2020-10-29

Reporting Person: Cheng Isaac (Director)

More from Atea Pharmaceuticals, Inc.

Proxy Solicitation & Information Statement 2026
Apr 27
Major Shareholding Notification 2026
Feb 9
Director's Dealing 2026
Feb 3
Director's Dealing 2026
Feb 3
Director's Dealing 2026
Feb 3
Director's Dealing 2026
Feb 3
Director's Dealing 2026
Feb 3
Director's Dealing 2026
Feb 3
Regulatory Filings 2026
Jan 8
Major Shareholding Notification 2025
Dec 5
View all filings →